Fecal Lactoferrin As A Diagnostic and Prognostic Marker in Egyptian IBD Patients

Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients

Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases

A Study of the Gut Microbiome in Egyptian Patients with active Crohn’s Disease

Use of Fecal Calprotectin as A Predictor of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Egyptian Patients

Clinico-Epidemiological Study of Colorectal Cancer Patients Diagnosed at Endoscopy Unit of Two University Hospitals in Cairo

Predictive value of trefoil factor 3 for identifying activity in ulcerative colitis patients: a comparison with fecal calprotectin and C-reactive protein

Evaluation of The Role of Fecal Microbiota Transplantation in The Management of Ulcerative Colitis in Egyptian Patients

Faecal Calprotectin as Reliable Non-invasive Marker to Assess the Severity of Mucosal Inflammation in Patients with Ulcerative Colitis

Clinical and biochemical response of treatment with anti-TNFα in Egyptian IBD patients: Zagazig University IBD Clinic experience